Literature DB >> 15174911

Excessive carotid in-stent neointimal formation predicts late cardiovascular events.

Martin Schillinger1, Markus Exner, Schila Sabeti, Jasmin Amighi, Oswald Wagner, Ramazanali Ahmadi, Erich Minar.   

Abstract

PURPOSE: To examine if excessive in-stent neointimal formation causing a subcritical stenosis may indicate enhanced vascular reactivity in response to injury, thus predicting late cardiovascular events.
METHODS: One hundred consecutive patients (64 men; median age 71 years) with high-grade internal carotid artery stenoses (68 asymptomatic, 32 symptomatic) underwent carotid artery stenting (CAS). High-sensitivity C-reactive protein (hs-CRP) was measured before CAS. Patients were monitored with duplex ultrasound for excessive in-stent neointimal formation (flow-compromising lumen diameter reduction >/=50%), critical restenosis (>/=70%), or the occurrence of late major adverse cardiovascular events (MACE) defined as myocardial infarction (MI), stroke, and death occurring later than 30 days poststenting.
RESULTS: Over a median 23-month follow-up, excessive neointimal formation was observed in 14 (14%) patients, restenosis in 2 (2%), and 30 late MACE in 25 [25%: 4 MIs, 2 ipsilateral strokes (in the patients with restenosis), 8 contralateral strokes, and 16 cardiovascular deaths]. Cumulative MACE-free survival rates at 6, 12, and 24 months were 92%, 84%, and 77%, respectively. Baseline hs-CRP levels were associated both with neointimal hyperplasia (p=0.024) and MACE (p=0.021). Patients with excessive neointimal formation exhibited a significantly increased adjusted risk for MACE (hazard ratio 3.56, p=0.010).
CONCLUSIONS: Excessive in-stent neointimal formation after CAS indicates an increased risk for late MACE, potentially reflecting a state of exaggerated vascular reactivity in response to injury. Inflammation, which is associated both with neointimal hyperplasia and MACE, seems a common characteristic of different vascular pathologies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174911     DOI: 10.1583/04-1214.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  3 in total

1.  Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Authors:  Tanushree Banerjee; S Joseph Kim; Brad Astor; Tariq Shafi; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2014-09-27       Impact factor: 8.860

Review 2.  Management of extracranial carotid artery disease.

Authors:  Yinn Cher Ooi; Nestor R Gonzalez
Journal:  Cardiol Clin       Date:  2015-02       Impact factor: 2.213

3.  Advanced intimal hyperplasia without luminal narrowing of leptomeningeal arteries in CADASIL.

Authors:  Hairong Dong; Haixia Ding; Kelly Young; Mila Blaivas; Paul J Christensen; Michael M Wang
Journal:  Stroke       Date:  2013-03-12       Impact factor: 7.914

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.